Pharmacy

Guidance for hospital and clinical-based pharmacies as well as regulations related to commercial pharmacies.
The American Hospital Association released a report last week showing that total drug spending per hospital admission increased 18.5% between FYs 2015 and 2017.
Boston Medical Center Grayken Center for Addiction, and DPH’s Bureau of Substance Addiction Services are sponsoring free buprenorphine “x-waiver” trainings across the state.
Last week, Sen. Bernie Sanders (I-Vermont), along with several Democratic Senate and House members, including House Oversight Committee Chairman Elijah Cummings (D-Md.), announced the release of three bills intended to lower drug prices.
A U.S. District Court has issued a permanent injunction to CMS, halting the federal government’s nearly 30% reduction in reimbursements to certain hospital outpatient departments purchasing drugs through the 340B program.
MHA has released guidelines to assist hospitals develop appropriate programs to administer and/or prescribe Medication for Addiction Treatment in their EDs or satellite emergency facilities.
As 2019 begins, here are a few key developments that should occur.
The Board of Registration in Pharmacy’s much anticipated regulations on how a pharmacy can conduct sterile compounding will have unintended consequences that will increase costs and disrupt patient care.
DPH recently released a notice outlining new requirements for providers prescribing benzodiazepines.
In Mass., optimism over a federal opioid bill is mixed with concern over an impending threat to the state's behavioral health system
The American Hospital Association last week announced 340B drug program “good stewardship principles.”
In the battle against the opioid epidemic, the Centers for Disease Control and Prevention (CDC) is seeking data from hospitals across the U.S.
AHA and other hospital interests filed suit in U.S. District Court to stop a nearly 30% reduction in Medicare payments to hospitals for purchase of outpatient drugs under the 340B program.
The FDA has awarded a contract to develop evidence-based guidelines for appropriate opioid analgesic prescribing.
Last week, Gov. Charlie Baker signed two pieces of legislation of interest to the hospital community.
In a 37-0 vote last Thursday, the Massachusetts Senate passed “An Act for Prevention and Access to Appropriate Care and Treatment of Addiction.”
The Massachusetts House of Representatives voted unanimously last Wednesday to pass a sweeping, multi-part bill to fight the opioid crisis.
Last week, the Centers for Medicare and Medicaid Services responded to the state’s 1115 Medicaid Waiver request that had been filed last September.
Last week, MHA, working with member facilities, released two documents to assist hospitals in addressing a trend of patients misusing opioids within facilities.
The Massachusetts House of Representatives could begin consideration as early as tomorrow on a massive healthcare reform bill.
President Trump signed into law the Right to Try Act of 2017, which will allow terminally ill patients to try certain investigational drugs.

Resources

Click on the links below for easy access to important information related to state healthcare issues and advocacy.
Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.
To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites:
MHA has also developed the following documents for your information and benefit: